CYBB and disseminated peritoneal leiomyomatosis: Other possible mechanisms have been also documented, including altering circulating levels of uremic toxins 17, 20, tumor necrosis factor alpha (TNF-⍺), plasma nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX2) 18, SCFAs and bile acids 21 in association with changes of gut microbiota in patients receiving LPD.